CLINICAL TRIALS PROFILE FOR TECVAYLI
✉ Email this page to a colleague
All Clinical Trials for TECVAYLI
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05972135 ↗ | Outpatient Administration of Teclistamab for Multiple Myeloma | Recruiting | Janssen Research & Development, LLC | Phase 2 | 2023-10-23 | This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients |
NCT05972135 ↗ | Outpatient Administration of Teclistamab for Multiple Myeloma | Recruiting | SCRI Development Innovations, LLC | Phase 2 | 2023-10-23 | This is a phase II study to evaluate the Outpatient Administration of Teclistamab in Multiple Myeloma Patients |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TECVAYLI
Condition Name
Clinical Trial Locations for TECVAYLI
Trials by Country
Clinical Trial Progress for TECVAYLI
Clinical Trial Phase
Clinical Trial Sponsors for TECVAYLI
Sponsor Name